Results 41 to 50 of about 1,465,884 (208)
False-Positive Accumulation of Metaiodobenzylguanidine in a Case with Acute Intermittent Porphyria [PDF]
, 2011 We report a 36-year-old woman presenting with hypertensive encephalopathy followed by bulbar palsy and quadriplegia. After an extensive screening for secondary causes of hypertension, the patient was suspected of having pheochromocytoma due to increased ...
Rie Ota +15 more
core +1 more source
A Propos D'une Forme Nerveuse Pure A Evolution Cyclique De Porphyrie Aigue [PDF]
Acta Medica Iranica, 1959 A case of acute porphyria with polynevrite is described. Evidence of porphyria has been formed in other members of the family.
Gharib, Zamani
doaj
Desensitization in patients with hypersensitivity to haem arginate: A case report
World Allergy Organization Journal, 2019 Background: Porphyria comprises a group of metabolic disorders caused by the irregular activities of enzymes within the haem biosynthetic pathway. This disease can provoke a large variety of symptoms.
Edgardo Chapman +3 more
doaj +1 more source
Nihon Naika Gakkai Zasshi, 1962 典型的な急性ポルフィリン症を経験し,かつ剖検する機会を得た.症例は32才の男.腹痛,高血圧,精神症状,四肢運動麻痺,横隔膜麻痺を主要症状とし,ついに呼吸麻痺のため死亡した.尿は入院期間中,終始,赤褐色ないしブドウ酒色を呈し,ポルフォビリノーゲン強陽性,コプロポルフィリン陽性,ウロポルフィリン弱陽性であつた.剖検により横隔膜神経は左右とも内鞘は浮腫状を呈し,髄鞘は顆粒状変性,崩壊,脱髄などの所見を認め,軸素にも部位的に腫張,顆粒状変性,断裂などを認めた.このことは本症の横隔膜麻痺を裏づける意味あるものと考える.
AWAYA, Hironobu +2 more
openaire +3 more sources
British Journal of Haematology, EarlyView.Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Gaurav Joshi +3 more
wiley +1 more source
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
Clinical Endocrinology, EarlyView.ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
Tolerability of hormonal treatments in acute hepatic porphyria patients
Internal Medicine Journal, EarlyView.Abstract Background Acute hepatic porphyria (AHP) flares have been associated with female hormones and the use of hormonal treatments. Women with AHP are traditionally advised to avoid exogenous oestrogen and progesterone, limiting options for contraception and management of menorrhagia, dysmenorrhoea and menopausal symptoms.
Andjela Arandjelovic +2 more
wiley +1 more source
Drug-associated porphyria: a pharmacovigilance study
Orphanet Journal of Rare DiseasesBackground The potentially fatal attacks experienced by porphyria carriers are triggered by various porphyrinogenic drugs. However, determining the safety of particular drugs is challenging. Methods We retrospectively used the U.S.
Qi Wang +4 more
doaj +1 more source
The Journal of Dermatology, Volume 53, Issue 10, Page 1525-1528, October 2026.ABSTRACT Physical urticaria is a subtype of chronic inducible urticaria characterized by wheals and/or angioedema triggered by physical stimuli. We report a refractory case of combined localized heat urticaria, delayed solar urticaria, and symptomatic dermographism in a 16‐year‐old girl.
Shuta Yoshitani +2 more
wiley +1 more source
HemaSphere, Volume 10, Issue 9, September 2026.Abstract Microcytic anemia is among the most common hematological abnormalities in clinical practice and is usually attributable to iron deficiency, thalassemia traits, or anemia of inflammation. A small but clinically important subset of patients, however, has inherited disorders of iron metabolism or heme synthesis presenting with persistent ...
Alexandros Makis +2 more
wiley +1 more source